Addressing malnutrition and metabolic health in non-communicable diseases through precision Nutrition: impact in quality of life and prognosis of lung cancer patients.

Malnutrition represents a major burden for a large part of the population and, in particular, for vulnerable population groups like lung cancer patients.

Lung cancer is a global health crisis, with over 2.2 million new cases in 2020 and profound societal and economic impacts.

Lung cancer patients suffer from reduced quality of life, psychological distress, comorbidities, and the challenges of frequent treatments, as well as malnutrition and metabolic complications.MENTORING seeks to enhance patients' nutritional and metabolic statuses by targeting deficiencies in macro- and micronutrients and restoring the microbiome and glycomic health profiles.

This will contribute to improving the overall quality of life of lung cancer patients, increasing treatment efficacy, and potentially enhancing their survival rates.

By combining dietary assessment, nutritional and clinical biomarkers, immune-inflammatory signatures, anthropometry, genetics, glycomics, lung and gut microbiome, and food-related metabolomics, we will develop holistic models able to predict individual responses to personalised dietary plans considering multiple nutritional and metabolic outcomes.

This precision nutrition approach will play a critical role in lung cancer care by customising dietary guidance based on an individual's genetic makeup, nutritional assessment, and health status to reduce cancer progression and increase quality of life.This collaborative effort is tailored to the specific needs of Lung cancer patients, but it has been built in order to make it easily translatable to any other vulnerable population suffering from malnutrition or metabolic impairments.

The ultimate goal of MENTORING is to enhance patients' nutritional and metabolic statuses by using validated multi-omics approaches, potentially transforming the healthcare landscape.